Core Nursing Explanation
Key Concept Analysis: This question tests the critical management of
Diabetic Ketoacidosis (DKA). DKA is characterized by hyperglycemia, ketosis, and metabolic acidosis. The primary goals of treatment are to correct fluid volume deficit, lower blood glucose, reverse ketosis, and correct electrolyte imbalances. A key principle is that
insulin is required to stop ketone production, which is the primary driver of the life-threatening acidosis. Even when blood glucose normalizes, insulin must continue to resolve the ketosis.
Answer Rationale: The client's blood glucose has dropped to
240 mg/dL, which is a significant improvement but still above the normal range (
70-110 mg/dL). However, the primary threat in DKA is the ongoing
ketoacidosis, not just the hyperglycemia.
Key Point! Insulin is the only hormone that suppresses lipolysis and halts ketone production. Stopping insulin would allow ketosis to recur. Therefore, the insulin infusion must continue. To prevent hypoglycemia while continuing insulin to clear ketones,
dextrose (5% or 10%) is added to the intravenous fluids. This provides a substrate for the insulin to act upon, allowing the insulin to continue suppressing ketogenesis without causing dangerously low blood sugar.
Distractor Analysis:
Watch out for confusion! Option ① (Discontinue insulin) is dangerous. Stopping insulin would allow ketosis to resume, potentially worsening acidosis. Insulin is continued until the anion gap closes and ketones are cleared.
Option ② (Increase normal saline) addresses fluid resuscitation, which is a
separate and initial priority. By this stage, the client's glucose is dropping, indicating insulin is working. The question is focused on preventing complications from the
insulin therapy itself, not on initial volume expansion.
Option ④ (Switch to subcutaneous insulin) is incorrect during the acute phase of DKA management. Intravenous insulin provides immediate, titratable control. Subcutaneous absorption can be erratic in a volume-depleted patient. The switch to subcutaneous insulin typically occurs
after the acidosis has resolved and the patient is stable and able to eat.
Related Concepts: This integrates knowledge of DKA pathophysiology, insulin pharmacology, and fluid/electrolyte management. Remember the "two-track" approach in DKA: correct hyperglycemia AND correct acidosis/ketosis. The blood glucose level is only one parameter; monitoring serum ketones, bicarbonate levels, and the anion gap is crucial to determine when DKA has resolved.
Concept Summary
| Concept | Explanation |
|---|
| DKA Pathophysiology | Absolute insulin deficiency leads to hyperglycemia, lipolysis, ketone production (beta-hydroxybutyrate, acetoacetate), and metabolic acidosis. |
| Primary Treatment Goal | Reverse ketosis and acidosis, not just lower blood sugar. |
| Role of Insulin in DKA | Stops ketone production, promotes glucose uptake, lowers blood sugar. |
| Dextrose Addition Rationale | Prevents hypoglycemia while allowing continued insulin infusion to clear residual ketones. |
| Resolution Criteria | Blood glucose < 200 mg/dL, serum bicarbonate > 15 mEq/L, venous pH > 7.3, anion gap closed. |
Side-by-Side Comparison!
| Condition | Diabetic Ketoacidosis (DKA) | Hyperosmolar Hyperglycemic State (HHS) |
|---|
| Typical Onset | Rapid (hours) | Slower (days to weeks) |
| Key Lab Feature | Ketosis & Acidosis (pH < 7.3) | Severe hyperglycemia & hyperosmolality (Watch out for confusion!) Minimal/no ketosis |
| Blood Glucose | Usually > 250 mg/dL | Extremely high, often > 600 mg/dL |
| Insulin Therapy | Continuous IV infusion; add dextrose when glucose ~200 mg/dL | Lower insulin doses often needed; watch for rapid glucose drop |
| Fluid Deficit | Moderate (3-6 L) | Severe (8-12 L) |
Anatomy, Physiology & Pharmacology Points
- Physiology: Insulin inhibits hormone-sensitive lipase in adipose tissue. Without insulin, fats break down into free fatty acids, which the liver converts into ketone bodies (acetoacetate, beta-hydroxybutyrate), causing metabolic acidosis.
- Pharmacology: Regular insulin is used for IV infusion because it has a rapid onset and short duration, allowing for precise titration. When adding dextrose, a common protocol is to switch the IV fluid to D5 0.45% NaCl or D5 0.9% NaCl.
- Lab Values: Monitor blood glucose hourly, electrolytes (especially potassium) every 2-4 hours, and venous blood gas/anion gap to track resolution of acidosis.
Memory Tips
- Mnemonic for DKA Treatment Priorities: "Fluids, Insulin, Electrolytes, Dextrose" (FIED). Fluids first, then Insulin, watch Electrolytes (K+!), add Dextrose to prevent hypoglycemia.
- Clinical Pearl: "Don't turn off the insulin until the ketones are gone. Feed the insulin with sugar (dextrose) so it can keep working."
High-Frequency NCLEX Topics
The NCLEX frequently tests the
rationale behind DKA interventions, not just the steps. Be prepared for questions on:
- Priority nursing assessments (neurological status, respiratory pattern for Kussmaul respirations, fluid balance).
- Interpreting lab trends (what does a falling glucose but persistent acidosis mean?).
- Managing complications of therapy (e.g., hypokalemia from insulin shifting potassium into cells).
- Patient education to prevent recurrence.
Watch Out for Question Variations!
- Symptom Identification: "A client with DKA is experiencing confusion and fruity breath odor. Which finding should the nurse correlate with this?" (Answer: Metabolic acidosis).
- Priority Intervention: "The nurse is caring for a client newly admitted with DKA. Which action should the nurse take first?" (Answer: Initiate IV fluid resuscitation with 0.9% NaCl).
- Evaluation of Effectiveness: "Which finding indicates to the nurse that treatment for DKA is effective?" (Answer: Closure of the anion gap, resolution of ketonuria).
- Medication Administration: "The nurse is preparing to administer IV potassium to a client with DKA. Which client finding requires immediate notification of the provider?" (Answer: Urine output < 30 mL/hr).